Live
GLAXO logoGLAXOstock

Glaxosmithkline Pharmaceuticals Ltd

₹2,195
-0.28%
Open
₹2,209.95
High
₹2,210
Low
₹2,170
Volume
239.1K

Price chart

Daily close · downsampled 5-year history

2021-06-21 · ₹1,535.452026-06-18 · ₹2,192.05

Instrument details

MB Code
MBEQU3830
Type
stock
ISIN
INE159A01016
BSE
500660

Latest earnings

Q4FY26 declared

Quarter
Mar 2026
Revenue
995.3 Cr
Net profit
277.86 Cr
EPS
16.4
YoY revenue
+2.15%

Price returns

Historical performance

1 day
-0.31%
1 month
-8.24%
3 months
-7.93%
1 year
-33.26%
3 years
+54.96%
5 years
+44.64%

Technicals

Indicator consensus

Bullish
13
Neutral
6
Bearish
27
RSI 55.81(Neutral)

Corporate timeline

Price chart events · 1 year

Dividend
2026-05-29
{"amount":57}
News
2026-05-15
{"description":"GlaxoSmithKline Pharmaceuticals reported Q4 FY2026 earnings, with full-year EBITDA up 11% and PAT crossing 1,000 for the first time, highlighting strong profitability and operational growth.","url":"https://finance.yahoo.com/sectors/healthcare/articles/glaxosmithkline-pharmaceuticals-ltd-bom-500660-010136632.html","sentiment":"Positive","domain":"Yahoo Finance"}
News
2026-02-09
{"description":"On February 9, 2026, GlaxoSmithKline Pharmaceuticals Ltd reported a 28.6% increase in Q3 net profit to ₹295.6 crore, driven by a 9.7% rise in revenue to ₹1,041 crore. EBITDA rose 27.2%, and operating margin improved to 35.6%.","url":"https://www.cnbctv18.com/market/stocks/glaxosmithkline-share-price-q3-net-profit-surges-29-on-higher-revenue-and-ebitda-19845718.htm","sentiment":"Positive","domain":"CNBCTV18"}
News
2025-06-28
{"description":"The IPO details for GlaxoSmithKline Pharmaceuticals Ltd. include the Issue Open and Close Dates, along with information on subscription and allotment status.","url":"https://economictimes.indiatimes.com/glaxosmithkline-pharmaceuticals-ltd/ipos/companyid-13715.cms","sentiment":"Neutral","domain":"Indiatimes"}